STIM1 and neoplasm: Targeting of STIM1 by knockdown or pharmacological inhibition of the store-operated calcium entry (SOCE) was shown to suppress tumor metastasis in melanoma, hepatocellular carcinoma, colorectal cancer and breast cancer [30,31,32,33] and sensitized cancer cells’ response to therapy [34].